(Q33369470)

26 July 2017

title

Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma (English)

1 reference

26 July 2017

6

Ruey-Long Hong

1 reference

26 July 2017

Chuan-Cheng Wang

1

1 reference

26 July 2017

Jang-Yang Chang

2

1 reference

26 July 2017

Tsang-Wu Liu

3

1 reference

26 July 2017

Chin-Yu Lin

4

1 reference

26 July 2017

Yu-Chieh Yu

5

1 reference

26 July 2017

publication date

1 January 2006

1 reference

26 July 2017

1 reference

26 July 2017

volume

28

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

74-80

1 reference

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases

26 July 2017

cites work

1 reference

Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.

21 January 2018

1 reference

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

7 January 2021

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma

1 reference

7 January 2021

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

7 January 2021

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

7 January 2021

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

1 reference

7 January 2021

Chemotherapy for nasopharyngeal carcinoma. A ten-year experience

1 reference

7 January 2021

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

7 January 2021

Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience

1 reference

7 January 2021

Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan

1 reference

7 January 2021

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

7 January 2021

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx

1 reference

7 January 2021

Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis

1 reference

7 January 2021

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study

1 reference

7 January 2021

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

7 January 2021

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

1 reference

7 January 2021

Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma

1 reference

7 January 2021

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

7 January 2021

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

1 reference

7 January 2021

Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma

1 reference

7 January 2021

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

1 reference

7 January 2021

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

7 January 2021

Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Onc

1 reference

7 January 2021

Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial

1 reference

7 January 2021

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20310

1 reference

26 July 2017

1 reference